Notably, a high frequency of HLA-DR+CD38hi CD8+ T cells strongly correlated with severe lymphopenia, systemic inflammation, and tissue injury, suggesting a predictive value of this cell population for disease progression in COVID-19 patients. This evidence concerns the gene CD8A and COVID-19.